National Key Research and Development Program of China,Grant/Award Number:2022ZD0210100;Beijing Nova Star Program,Grant/Award Number:2022002;Natural Science Foundation of Beijing and Haidian Collaboration Foundation,Grant/Award Number:L232079;National Natural Science Foundation of China,Grant/Award Number:82172608,82273343,81902975 and 82101356;Capital Medical University Fund for Excellent Young Scholars,Grant/Award Number:KCB2304。
Background:Medulloblastoma(MB)is one of the most common malignant brain tumors that mainly affect children.Various approaches have been used to model MB to facilitate investigating tumorigenesis.This study aims to com...
Research Fund of Jianghan University,Grant/Award Number:2021jczx-002;Natural Science Foundation of Hubei Province,Grant/Award Number:2024AFB941 and 2024AFD241;Wuhan Science and Technology Project,Grant/Award Number:2023010201020448;National Natural Science Foundation of China,Grant/Award Number:82204416。
The high morbidity and mortality of colorectal cancer(CRC)is a major challenge in clinical practice.Although a series of alternative research models of CRC have been developed,appropriate orthotopic animal models that...
National Key Basic Research and Development Program of China(2019YFA0801402,2018YFA0107200,2018YFA0801402,2018YFA0800100);Strategic Priority Research Program of the Chinese Academy of Sciences(XDA16020501,XDA16020404);National Natural Science Foundation of China(32130030,31900454).
Continuous immunosuppression has been widely used in xenografts into non-human primate brains.However,how immune responses change after transplantation in host brains under continuous immunosuppressive adminis-tration...
supported by grants from the National Natural Science Foundation of China(Nos.32170729 and 8216100622);Major Project Granted by the Gansu Provincial Science and Technology Department(No.21ZD4FA015);the Gansu Provincial Science and Technology Plan Project 21(No.JR1RA144);the Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital(No.CY2020-MS10);Gansu Province Science Foundation for Youths(20JR5RA316);the Cuiying Science and Technology Innovation Project of Lanzhou University Second Hospital(Nos.CYXZ2020-10,CY2020-MS10,CYXZ2021-27,and CY2022-ZD-01).
Background:Gastric cancer(GC),a malignant tumor with poor prognosis,is one of the leading causes of cancer-related deaths worldwide;consequently,identifying novel therapeutic targets is crucial for its corresponding t...
supported by Global-Learning&Academic research institution for Master’s PhD students,Postdocs(G-LAMP)Program through the National Research Foundation of Korea(NRF)funded by the Ministry of Education(RS-2023-00285390 to Daechan Park);the NRF grant funded by the Ministry of Science and ICT(RS-2024-00341899 to Daechan 2022R1A2C2011122 to Jin-Young Jang);supported by DNA Link,Inc.,and there is no conflict of interest.
Patient-derived xenograft(PDX)models have been used to explore therapeutic opportunities for pancreatic ductal adenocarcinoma(PDAC)[1].Although original tumor characteristics are altered by cancer-stromal interactions...
funded by the Beijing Advanced Innovation Center for Genomics and the National Natural Science Foundation of China(Grant No.91959110).
Colorectal cancer(CRC)is a highly heterogeneous cancer and exploring novel therapeutic options is a pressing issue that needs to be addressed.Here,we established human CRC tumor-derived organoids that well represent b...
the Scientific Research Project Funding of Jianghan University(2023zd053);The Scientific Research Project Funding of Jianghan University(2021jczx-002).
Malignant tumor is the second leading cause of death due to its high incidence, lack of effective treatment and poor prognosis. The evaluation of anticancer drugs used to based on NCI-60 cell line models, but the limi...
Aim:Cell division cycle 25B(CDC25B)belongs to the CDC25 family of phosphatases that regulate cell cycle progression.CDC25B also contributes to tumor initiation and progression,but no connection between CDC25B levels a...
supported by the Anhui Provincial Natural Science Foundation(2308085MH279);the Fundamental Research Funds for the Central Universities(WK9110000156);Key Research and Development Program of Anhui Province(202104j07020025);2021 Anhui Provincial Quality Engineering Project for Higher Education Institutions(2021jyxm1778).
Glioblastoma(GBM)is among the most common and aggressive adult central nervous system tumors.One prominent charac-teristic of GBM is the presence of abnormal microvessels.A significant correlation between angiogenesis...
The journey to implement cancer genomic medicine(CGM)in oncology practice began in the 1980s,which is considered the dawn of genetic and genomic cancer research.At the time,a variety of activating oncogenic alteration...